Bio-Techne
TECH
#1989
Rank
NZ$16.63 B
Marketcap
NZ$106.77
Share price
-2.93%
Change (1 day)
-14.63%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.68 Billion

According to Bio-Techne's latest financial reports the company's total debt is NZ$0.68 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-06-30NZ$0.68 B-7.27%
2023-06-30NZ$0.74 B42%
2022-06-30NZ$0.52 B-13.1%
2021-06-30NZ$0.60 B-10.56%
2020-06-30NZ$0.67 B-10.56%
2019-06-30NZ$0.75 B50.1%
2018-06-30NZ$0.50 B6.61%
2017-06-30NZ$0.46 B251.77%
2016-06-30NZ$0.13 B17.62%
2015-06-30NZ$0.11 B668.16%
2014-06-30NZ$14.77 M
2006-06-30NZ$22.16 M3.75%
2005-06-30NZ$21.36 M-13.81%
2004-06-30NZ$24.79 M-15.52%
2003-06-30NZ$29.34 M-20.98%
2002-06-30NZ$37.14 M-20.26%
2001-06-30NZ$46.57 M10.75%
2000-06-30NZ$42.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
NZ$61.76 B 8,944.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$2.41 B 253.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$33.47 B 4,803.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$29.17 B 4,173.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.68 B 439.25%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
NZ$36.07 B 5,182.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$5.19 M-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA